Clinical Trial: Clinical Trial Comparing Single-administration of DA-5222 and Co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in Healthy Adult Subjects in Fed State

U.S., July 2 -- ClinicalTrials.gov registry received information related to the study (NCT07046715) titled 'Clinical Trial Comparing Single-administration of DA-5222 and Co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in Healthy Adult Subjects in Fed State' on June 23.

Brief Summary: This study is to compare pharmacokinetics and safety profiles of single-administration of DA-5222 and co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in healthy adult subjects in fed state

Study Start Date: Aug., 2025

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: DA-5222

single dose administration (DA-5222 one tablet once a day)

DRUG: DA-5222-R1

single dose administration (DA-5222-R1 one tablet once a day)

DR...